Navigation Links
Access Pharmaceuticals Announces $2.7 Million New Equity
Date:1/29/2008

, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill cancer cells; Alchemix, a chemotherapeutic agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our ability to close the financing transaction, early results from our clinical trial, Access' plans to continue and initiate clinical trials, the value of its products in the market, its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-KSB and other reports
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
2. Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
3. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
4. Access Pharmaceuticals Announces $19.5 Million Recapitalization
5. Access Genetics Announces New Executive Appointments
6. Pharmasset Accesses up to $30 Million of Working Capital
7. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
8. CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care
9. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
10. Access Highlighted in Recent BusinessWeek Article
11. Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)...-FirstCall/ -- Rigel,Pharmaceuticals, Inc. (Nasda...s,senior management team will host a conference c... 7, 2008, at 4:00 p.m. PST, to discuss the results...al Syk kinase inhibitor, in,patients with B-cell ...and Webcast Information , To access the liv...
(Date:12/3/2008)...EC CITY, Dec. 3 /PRNewswire-FirstCall/ - AEterna Z... biopharmaceutical company focused on endocrine th...d the transaction under the previously announced p...oyalty Partners, L.P. ("CHRP") relating to AEterna...Cetrotide(R) covered by its license agreement with...
(Date:12/3/2008)...verall survival of 27.5 months, for OGX-011 i...16.9, months overall survival for docetax...survival benefit milestone results in release of,...f OGXI., , , BOTHELL, WA and VANCOUVER, De...icals, Inc. (NASDAQ: OGXI ) today announced posi...
(Date:12/3/2008)...r changes in the U.S. and worldwide stock markets,...ted on once again: tens of thousands of new jobs c...345,000.The MedZilla.com Employment Report analyze...indings. , Seattle, WA (V...nced some subtle and – some might say &ndash...
Breaking Biology Technology:Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphoma Presented at ASH 2AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 2AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners 3OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health 3
...t separates good business executives from excellen... Heritage Dictionary defines vision as unusual com...nt foresight. Many people claim to be visionaries,... ability. During the Internet dot-com fiasco, many... interesting game, but when the real challenges ap...
... biotech festivals weren,t the only indicators th..., ,That same week, the Illinois Biotechnology Ind...irman Jim L. Tyree, vice president of global busin...ies (not to be confused with Mesirow ,s CEO). T...is stepping up to the plate to support biotechnolo...
...,You did it; you brought Bill Gates to his tender ...hroughout the Microsoft campus. ,Curses, you worm ...ut drowning out the sawing sound of the gnashing o... hear Billy saying it: "I will, I will, I promise ..., ,Wow, if only the U.S. antitrust lawyers had tho...
...ogy analysts, consultants and executives are repor...ding will increase in the second half of 2003, whi...ound in IT spending for 2004. , ,Steve Haroldson, ...d, Technology spending is showing signs of recover...ver the last year Ive asked them how their busines...
Other Biology Technology:Leadership is all about Vision 2Leadership is all about Vision 3Abbott Executive Jim Tyree Takes IBIO Helm 2Abbott Executive Jim Tyree Takes IBIO Helm 3Abbott Executive Jim Tyree Takes IBIO Helm 4Abbott Executive Jim Tyree Takes IBIO Helm 5Abbott Executive Jim Tyree Takes IBIO Helm 6Abbott Executive Jim Tyree Takes IBIO Helm 7Abbott Executive Jim Tyree Takes IBIO Helm 8Open Letter: Blasted Worm 2Open Letter: Blasted Worm 3IT Spending to Increase in Second Half of 2003 2IT Spending to Increase in Second Half of 2003 3IT Spending to Increase in Second Half of 2003 4IT Spending to Increase in Second Half of 2003 5
(Date:12/3/2008)..., it,s easy to forget that a dam and pond stood fo...s Franbrook Farm Research Station in southwestern ...nd acres of plants, both native and weedy, now car...s, memories of the dam remain, and by digging into...e now unearthing them. Writing in a special issue ...
(Date:12/3/2008)...od is big and heavy, with seemingly little prayer ... yet, like a grounded teenager who knows where the...onable chance of escape. , University of Florida...mental landscape devoted to wildlife corridors gr...ve discovered the pea and similar species share, g...
(Date:12/3/2008)...As the United States continues to develop alternat...dence, cellulosic-based ethanol has emerged as one...n stover remains the most popular source available...ated with the removal of corn fodder as a cellulos...nmental concern. , In the November-December 20...
(Date:12/3/2008)...rated how a technique using lasers could be employ...e campaign supports one of the main objectives of ...A-SCOPE (Advanced Space Carbon and climate Observa...Earth Explorer missions that has just completed as...e other five, will be presented to the science com...
Breaking Biology News(10 mins):Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Rooted plants move mysteriously down greenways, scientists say 2Rooted plants move mysteriously down greenways, scientists say 3Managing carbon loss 2ESA tests laser to measure atmospheric carbon dioxide 2ESA tests laser to measure atmospheric carbon dioxide 3Dr Tracy Rupp wins the National Sleep Foundation Young Investigator Award 15292 1Kansas Kids Kick Butts on April 2 15291 1Kansas Kids Kick Butts on April 2 15291 2Kansas Kids Kick Butts on April 2 15291 3Connecticut Kids Kick Butts on April 2 15288 1Connecticut Kids Kick Butts on April 2 15288 2Connecticut Kids Kick Butts on April 2 15288 3Georgia Kids Kick Butts on April 2 15285 1Georgia Kids Kick Butts on April 2 15285 2Georgia Kids Kick Butts on April 2 15285 3
...y by McGill University Professor of Psychology Dr...., previously suspected but unproven even among hig...In research published online June 29 in the journa...Langford and their colleagues in the Pain Genetics...t were co-housed (that is, familiar to each other)...
...bye-bye," said one 3 and a half-year old child, bo... restored hearing nine months earlier. That,s the ...ting session that involved play with a toy train s...d a cochlear implant 31 months earlier made more s...to stand there with that noise and now -- Woo! Woo...
...cher Zafira Castaño has discovered that the loss o...ors tumor growth. This was the conclusion that the...n which she defended at the University of Navarra....rior studies from her laboratory, which demonstrat...ls that coat the normal lung, and which, neverthel...
...ch shows that a protein made by a cancer-causing v...plication is in fact critically needed by the viru...e study examined the human T lymphotropic virus ty...he protein is one of the virus, so-called accessor...laboratory-grown cells suggested that the virus co...
Other Biology News:With cochlear implants, earlier use leads to better speech 2With cochlear implants, earlier use leads to better speech 3Cancer virus protein needed for successful infection 2
11(R)-HETE is biosynthesized by the 11(R)-LOs of the sea urchin, S. purpuratus, and the fresh water hydra, H. vulgaris. The biological activity of 11(R)-HETE relates to oocyte maturation and tentacle
The PowerEase 500 Power Supply is designed specifically for mini-gel electrophoresis. It offers extensive programming capabilities including eight pre-set and four custom methods for you to set to yo
TNF-R2 (L-20)
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25.
Biology Products: